抗生素摄入对撒哈拉以南非洲产超广谱β-内酰胺酶肠杆菌目细菌发病率的影响:一项基于社区的纵向研究结果
该纵向研究在加纳库马西4家独立药房招募购买抗生素的药房顾客,以购买非抗生素药物者为对照,用直肠拭子和ESBL-PE选择性培养基筛查,并对基线阴性者随访至28天。基线404名参与者中302名(75%)定植ESBL-PE;符合方案随访的63人中,抗生素组与对照组各次随访累积比例均无显著差异。作者认为随访28天内定植率进一步升高且与抗生素摄入无关,需进一步开展非洲社区纵向研究。
要点
- 基线404名药房顾客中302名(75%)肠道定植ESBL-PE,高于预期。
- 基线阴性并完成随访的63人中,抗生素组与对照组各次随访累积比例无显著差异。
- 28天随访期间肠道ESBL-PE定植率进一步升高,与是否摄入抗生素无关。
核心结论
- 药房顾客基线肠道ESBL-PE定植率高于预期,28天随访期间定植率进一步升高,且与抗生素摄入无关。
- 作者认为这一发现需在门诊患者抗生素治疗中加以考虑,并强调迫切需要改进预防策略、开发新抗生素及潜在的清除策略。
研究设计与样本
- 研究在加纳库马西4家独立药房开展,采用直肠拭子和ESBL-PE选择性培养基筛查。
- 招募购买抗生素的药房顾客,以购买非抗生素药物者为对照,基线ESBL-PE阴性者提供随访拭子至28天。
- 基线共404名参与者,其中302名(75%)定植ESBL-PE;基线阴性并接受符合方案随访者63人,包括28名使用抗生素者和35名对照。
主要发现
- 第一次随访时抗生素组与对照组ESBL-PE累积比例分别为71%(20/28)和54%(19/35),p 0.258。
- 第二次随访时两组累积比例分别为86%(24/28)和80%(28/35),p 0.741。
- 第三次随访时两组累积比例分别为86%(24/28)和94%(33/35),p 0.393。
临床怎么用
- 作者认为这一发现需在门诊患者抗生素治疗中加以考虑,并强调迫切需要改进预防策略、开发新抗生素及潜在的清除策略。
局限性
- 作者指出需要进一步开展非洲社区(也包括药房以外场所)的ESBL-PE纵向研究。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVES: The global prevalence of intestinal extended-spectrum β-lactamase-producing Enterobacterales (ESBL-PE) is approximately 17% in communities, with significant variations among regions. This longitudinal study aimed to assess the impact of antibiotic intake on the incidence of intestinal ESBL-PE in Ghanaian pharmacy customers outside of hospitals. METHODS: Screening for ESBL-PE was performed in four independent pharmacies in Kumasi, Ghana, using rectal swabs and an ESBL-PE-selective medium. Pharmacy customers purchasing antibiotics were recruited, and those buying non-antibiotic drugs served as controls. Participants who were negative for ESBL-PE provided follow-up swabs for up to 28 days. RESULTS: At baseline, 302 (75%) of 404 participants were colonized with ESBL-PE. Sixty-three participants who were negative for ESBL-PE at baseline received per-protocol follow-up, including 28 individuals who took antibiotics and 35 controls. The cumulative proportions of ESBL-PE in the antibiotics and control groups were 71% (20/28) and 54% (19/35) at the first follow-up (p 0.258), 86% (24/28) and 80% (28/35) at the second follow-up (p 0.741) and 86% (24/28) and 94% (33/35) at the third follow-up (p 0.393), respectively. DISCUSSION: The rate of intestinal ESBL-PE carriage among pharmacy customers outside of hospitals was higher than expected at baseline and further increased during the 28 days of follow-up, irrespective of antibiotic intake. This alarming finding needs to be considered in the antibiotic treatment of outpatients and emphasizes the urgent need for improved prevention strategies, development of new antibiotic drugs and potential future elimination strategies. Further longitudinal studies on ESBL-PE in African communities, also outside of pharmacy settings, are required.
引用
- Heinemann M, Kleinjohann L, Rolling T, et al. Impact of antibiotic intake on the incidence of extended-spectrum β-lactamase-producing Enterobacterales in sub-Saharan Africa: results from a community-based longitudinal study. Clin Microbiol Infect. 2022. PMID: 36150674. doi:10.1016/j.cmi.2022.09.008
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。